Physiology of Human Cortical Neurons Adjacent to Cavernous Malformations and Tumors

Epilepsia

Volumn 44, Issue 11, 2003, Pages 1413-1419

  Williamson, Anne ^a   Patrylo, Peter R ^b   Lee, Sunghoon ^a   Spencer, Dennis D ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cavernous malformations; Epileptogenesis; Focal neocortical seizures

Indexed keywords

ACTION POTENTIAL; ADULT; ARTICLE; ASTROCYTOMA; BRAIN MALFORMATION; BRAIN TUMOR; CHILD; EPILEPSY; EPILEPTOGENESIS; EVOKED RESPONSE; EXCITATORY POSTSYNAPTIC POTENTIAL; FOCAL EPILEPSY; GLIOMA; HIPPOCAMPUS; HUMAN; HUMAN CELL; NEOCORTEX; NERVE CELL; NEUROPHYSIOLOGY; OLIGODENDROGLIOMA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CEREBRAL CORTEX; CHILD; CULTURE TECHNIQUES; ELECTRIC STIMULATION; EPILEPSIES, PARTIAL; EXCITATORY POSTSYNAPTIC POTENTIALS; FEMALE; GLIOMA; HEMANGIOMA, CAVERNOUS, CENTRAL NERVOUS SYSTEM; HIPPOCAMPUS; HUMANS; MALE; MEMBRANE POTENTIALS; MIDDLE AGED; NEURAL INHIBITION; NEURONS; SUPRATENTORIAL NEOPLASMS; SYNAPTIC TRANSMISSION;

EID: 0242407510     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2003.23603.x     Document Type: Article

References (39)

1. Kim JH. Pathology of seizure disorders. Neuroimaging Clin North Am 1995;5:527-45.
2. Avoli M, Williamson A. Functional and pharmacological properties of human neocortical neurons maintained in vitro. Prog Neurobiol 1996;48:519-54.
3. Tasker JG, Hoffman NW, Kim YI, et al. Electrical properties of neocortical neurons in slices from children with intractable epilepsy. J Neurophysiol 1996;75:931-9.
4. Telfeian AE, Spencer DD, Williamson A. Lack of correlation between neuronal hyperexcitability and electrocorticographic responsiveness in epileptogenic human neocortex. J Neurosurg 1999;90:939-45.
5. Kohling R, Hohling JM, Straub H, et al. Optical monitoring of neuronal activity during spontaneous sharp waves in chronically epileptic human neocortical tissue. J Neurophysiol 2000;84:2161-5.
6. Kohling R, Qu M, Zilles K, et al. Current-source-density profiles associated with sharp waves in human epileptic neocortical tissue. Neuroscience 1999;94:1039-50.
7. Jafar J, Awad I, Rosenwasser R. Vascular malformations of the central nervous system. Philadelphia: Lippincott Williams & Wilkins, 1999.
8. Robinson JR, Awad IA, Little JR. Natural history of the cavernous angioma. J Neurosurg 1991;75:709-14.
9. Gunel M, Laurans MS, Shin D, et al. KRITI, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein. Proc Natl Acad Sci U S A 2002;99:10677-82.
10. Sahoo T, Johnson EW, Thomas JW, et al. Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet 1999;8:2325-33.
11. Otten P, Pizzolato GP, Rilliet B, et al. [131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies]. Neurochirurgie 1989;35:82-3, 128-31.
12. Robinson JR Jr, Awad IA, Masaryk TJ, et al. Pathological heterogeneity of angiographically occult vascular malformations of the brain. Neurosurgery 1993;33:547-54; discussion 554-5.
13. Del Curling O Jr, Kelly DL Jr, Elster AD, et al. An analysis of the natural history of cavernous angiomas. J Neurosurg 1991;75:702-8.
14. 3-induced epileptogenic foci in the rat brain. Epilepsia 1990;31:15-26.
15. Vives KP, Awad IA. Overview: vascular causes of epilepsy. In: Kotagal P, Luders H, eds. The epilepsies: etiologies and prevention. New York: Academic Press, 1999:371-83.
16. Spencer DD, Spencer SS. Hippocampal resections and the use of human tissue in defining temporal lobe epilepsy syndromes. Hippocampus 1994;4:243-9.
17. Wolf H, Wiestler O, Surgical pathology of chronic epileptic seizure disorders. Brain Pathol 1993;3:371-80.
18. Schramm J, Kral T, Grunwald T, et al. Surgical treatment for neocortical temporal lobe epilepsy: clinical and surgical aspects and seizure outcome. J Neurosurg 2001;94:33-42.
19. Beaumont A, Whittle IR. The pathogenesis of tumour associated epilepsy. Acta Neurochir 2000;142:1-15.
20. Bartolomei JC, Christopher S, Vives K, et al. Low-grade gliomas of chronic epilepsy: a distinct clinical and pathological entity. J Neurooncol 1997;34:79-84.
21. Gunel M, Awad IA, Finberg K, et al. A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N Engl J Med 1996;334:946-51.
22. Williamson A. Excitability changes in epileptic human dentate gyrus and temporal neocortex. Adv Neurol 1999;79:795-804.
23. Foehring RC, Lorenzon NM, Herron P, et al. Correlation of physiologically and morphologically identified neuronal types in human association cortex in vitro. J Neurophysiol 1991;66:1825-37.
24. Patrylo PR, Dudek FE, Wuarin JP. Physiological unmasking of new glutamatergic pathways in the dentate gyrus of hippocampal slices from kainate-induced epileptic rats: electrographic seizures and new recurrent excitatory circuits in the dentate gyrus of hippocampal slices from kainate-treated epileptic rats. J Neurophysiol 1998;79:418-29.
25. Wuarin J-P, Dudek FE. Electrographic seizures and new recurrent excitatory circuits in the dentate gyrus of hippocampal slices from kainate-treated epileptic rats. J Neurosci 1996;16:4438-48.
26. Wuarin JP, Kim YI, Cepeda C, et al. Synaptic transmission in human neocortex removed for treatment of intractable epilepsy in children. Ann Neurol 1990;28:503-11.
27. Chen WR, Lee S, Kato K, et al. Long-term modifications of synaptic efficacy in the human inferior and middle temporal cortex. Proc Natl Acad Sci U S A 1996;93:8011-5.
28. McCormick D. GABA as an inhibitory neurotransmitter in human cerebral cortex. J Neurophysiol 1989;62:1018-27.
29. Telfeian AE, Connors BW. Layer-specific pathways for the horizontal propagation of epileptiform discharges in neocortex. Epilepsia 1998;39:700-8.
30. Engstrom ER, Hillered L, Flink R, et al. Extracellular amino acid levels measured with intracerebral microdialysis in the model of posttraumatic epilepsy induced by intracortical iron injection. Epilepsy Res 2001;43:135-44.
31. 3 causes spontaneous recurrent seizures. Exp Neurol 1998;153:123-7.
32. Kondziolka D, Bernstein M, Resch L, et al. Significance of hemorrhage into brain tumors: clinicopathalogical study. J Neurosurg 1987;67:852-7.
33. Gabrielsson B, Robson T, Norris D, et al. Effects of divalent metal ions on the uptake of glutamate and GABA from synaptosomal fractions. Brain Res 1986;384:218-23.
34. Ueda Y, Willmore LJ. Sequential changes in glutamate transporter protein levels during Fe(3 +)-induced epileptogenesis. Epilepsy Res 2000;39:201-9.
35. Ueda Y, Doi T, Tokumaru J, et al. Collapse of extracellular glutamate regulation during epileptogenesis: down-regulation and functional failure of glutamate transporter function in rats with chronic seizures induced by kainic acid. J Neurochem 2001;76:892-900.
36. Willmore LJ, Triggs WJ. Iron-induced lipid peroxidation and brain injury responses. Int J Dev Neurosci 1991;9:175-80.
37. Willmore LJ. Post-traumatic epilepsy: cellular mechanisms and implications for treatment. Epilepsia 1990;31(suppl 3):S67-73.
38. Kabuto H, Yokoi I, Ogawa N. Melatonin inhibits iron-induced epileptic discharges in rats by suppressing peroxidation. Epilepsia 1998;39:237-43.
39. Dudek FE, Spitz M, Hypothetical mechanisms for the cellular and neurophysiologic basis of secondary epileptogenesis: proposed role of synaptic reorganization. J Clin Neurophysiol 1997;14:90-101.